HomeCompareCDNAF vs MRK

CDNAF vs MRK: Dividend Comparison 2026

CDNAF yields 3.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDNAF wins by $645.3K in total portfolio value
10 years
CDNAF
CDNAF
● Live price
3.99%
Share price
$129.35
Annual div
$5.15
5Y div CAGR
54.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$702.1K
Annual income
$426,729.29
Full CDNAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CDNAF vs MRK

📍 CDNAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDNAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDNAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDNAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDNAF
Annual income on $10K today (after 15% tax)
$338.73/yr
After 10yr DRIP, annual income (after tax)
$362,719.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CDNAF beats the other by $354,391.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDNAF + MRK for your $10,000?

CDNAF: 50%MRK: 50%
100% MRK50/50100% CDNAF
Portfolio after 10yr
$379.4K
Annual income
$218,263.71/yr
Blended yield
57.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CDNAF
Analyst Ratings
2
Buy
Consensus: Buy
Price Target
$205.00
+58.5% upside vs current
Range: $205.00 — $205.00
Altman Z
2.0
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDNAF buys
0
MRK buys
0
No recent congressional trades found for CDNAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDNAFMRK
Forward yield3.99%2.76%
Annual dividend / share$5.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR54.3%32.7%
Portfolio after 10y$702.1K$56.8K
Annual income after 10y$426,729.29$9,798.13
Total dividends collected$652.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$205.00$128.54

Year-by-year: CDNAF vs MRK ($10,000, DRIP)

YearCDNAF PortfolioCDNAF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,315$614.90$11,206$366.19+$109.00CDNAF
2$13,110$1,003.31$12,650$502.35+$460.00CDNAF
3$15,704$1,676.40$14,407$694.19+$1.3KCDNAF
4$19,699$2,895.80$16,585$967.82+$3.1KCDNAF
5$26,317$5,238.24$19,342$1,363.89+$7.0KCDNAF
6$38,250$10,091.22$22,913$1,947.19+$15.3KCDNAF
7$62,078$21,150.81$27,662$2,823.89+$34.4KCDNAF
8$115,925$49,501.40$34,159$4,173.35+$81.8KCDNAF
9$257,342$133,302.20$43,337$6,308.80+$214.0KCDNAF
10$702,085$426,729.29$56,776$9,798.13+$645.3KCDNAF

CDNAF vs MRK: Complete Analysis 2026

CDNAFStock

Canadian Tire Corporation, Limited provides a range of retail goods and services in Canada. It operates in three segments: Retail, CT REIT, and Financial Services. The Retail segment retails automotive maintenance products and accessories, parts, tires as well as automotive repair and roadside assistance; kitchen, home organization, decor and essentials, home electronics, pet, and cleaning and consumable products; tools, hardware, paint, electrical, plumbing, home environment, and smart home products; and outdoor recreation, exercise, footwear and apparel, hunting, fishing, camping, and sporting goods. It also retails Christmas trees, lights and decor, Halloween décor and costumes, yard care and maintenance, and snow removal equipment; patio furniture, barbeques, pools, trampolines, outdoor power equipment and tools, plants and gardening supplies; backyard amusement, pool fun, and toys and games; gasoline; sporting goods and active wear; casual and industrial apparel and footwear; and outerwear, base-layer, and workwear. This segment offers its products under the Canadian Tire, Canadian Tire Gas, Mark's, PartSource, Helly Hansen, Party City, and SportChek brand names. This segment also participates in loyalty programs, as well as sells its products online. The CT REIT segment operates as a closed-end real estate investment trust that holds a portfolio of 368 properties comprising Canadian Tire stores, Canadian Tire anchored retail developments, industrial properties, a mixed-use commercial property, and development properties. The Financial Services segment provides financial and other ancillary products and services, including consumer credit cards, in-store financing, insurance products, and retail and broker deposits; and savings accounts and guaranteed investment certificates. Canadian Tire Corporation, Limited was founded in 1922 and is headquartered in Toronto, Canada.

Full CDNAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CDNAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDNAF vs SCHDCDNAF vs JEPICDNAF vs OCDNAF vs KOCDNAF vs MAINCDNAF vs JNJCDNAF vs ABBVCDNAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.